24 June 2026
Sepsis in newborns leaves doctors with only a few hours to save them. Known antibiotics are increasingly failing against drug-resistant bacteria, forcing clinicians to improvise with wide range of alternatives1.
An international clinical trial has begun recruiting newborns in India to address this growing dilemma in neonatal intensive care units. The trial, led by the Global Antibiotic Research and Development Partnership (GARDP), will test and rank multiple antibiotic combinations for neonatal sepsis, one of the leading causes of newborn deaths worldwide.